After further adjustment for age, BMI, sex, ALT, AST, and γ-GT levels in Model 3, there was no statistical difference in the association between FABP1 and the risk of hyperuricemia (OR, 95% CI = 1.022, 0.994–1.052, P = 0.125). Here, FABP1 is linked to hyperuricemia.